BOXR1030, an anti-GPC3 CAR with exogenous GOT2 expression, shows enhanced T cell metabolism and improved anti-cell line derived tumor xenograft activity
Taylor Hickman(Fulcrum Therapeutics (United States)), Amy Jensen-Smith
Cited by 32
Related Papers
No related papers found
Powered by citation graph analysis